| For: | Andrikopoulos GK, Pastromas S, Tzeis S. Flecainide: Current status and perspectives in arrhythmia management. World J Cardiol 2015; 7(2): 76-85 [PMID: 25717355 DOI: 10.4330/wjc.v7.i2.76] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v7/i2/76.htm |
| Number | Citing Articles |
| 1 |
Hermann A.M. Mucke. Drug Repurposing Patent Applications January–March 2015. ASSAY and Drug Development Technologies 2015; 13(6) doi: 10.1089/adt.2015.29017.patdrrr
|
| 2 |
A. Manaka, R. Uvarani. Molecular structure, spectroscopic features, in silico predictions, molecular docking and anticancer activity of 3,4',7,8-Tetrahydroxyflavone hydrate compound using DFT calculations. Proceedings of the Indian National Science Academy 2026; doi: 10.1007/s43538-025-00548-2
|
| 3 |
Michael Sampson. Antiarrhythmic drugs part 2: rhythm-control drugs. British Journal of Cardiac Nursing 2019; 14(10) doi: 10.12968/bjca.2019.0067
|
| 4 |
Alexandra Smith, Gregg Gerasimon. An electrocardiographic series of flecainide toxicity. Indian Pacing and Electrophysiology Journal 2019; 19(2) doi: 10.1016/j.ipej.2018.11.012
|
| 5 |
Alexandra Njegic, Claire Wilson, Elizabeth J. Cartwright. Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.01068
|
| 6 |
|
| 7 |
Sean P. Gaine, Hugh Calkins. Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy. Biomedicines 2023; 11(4) doi: 10.3390/biomedicines11041213
|
| 8 |
Miguel Aurrecoechea-Perea, Hebert David Ayala-More, Isaac Vidal-Valdivia, Teresa Gonzalo-Moreno, María Gota-Nieto. Class IC Atrial Flutter Presenting as a Wide Complex Tachycardia: Lessons from a Case Report. Iberoamerican Journal of Medicine 2026; 8(2) doi: 10.53986/ibjm.2026.0009
|
| 9 |
G. Andrei Dan. Resurrection of classical antiarrhythmic drugs. International Journal of Cardiology 2024; 412 doi: 10.1016/j.ijcard.2024.132300
|
| 10 |
Paul J. Wurtz, Joseph Pearman, Kelvin N.V. Bush. Failed Pacemaker Detection of Flecainide-Induced Atrial Flutter With One-to-One Atrioventricular Conduction. JACC: Case Reports 2025; 30(11) doi: 10.1016/j.jaccas.2025.103365
|
| 11 |
Paola Spitalieri, Rosa V. Talarico, Silvia Caioli, Michela Murdocca, Annalucia Serafino, Marco Girasole, Simone Dinarelli, Giovanni Longo, Sabina Pucci, Annalisa Botta, Giuseppe Novelli, Cristina Zona, Ruggiero Mango, Federica Sangiuolo. Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes. Journal of Molecular and Cellular Cardiology 2018; 118 doi: 10.1016/j.yjmcc.2018.03.012
|
| 12 |
Patrick Connell, Tarah A. Word, Xander H. T. Wehrens. Targeting pathological leak of ryanodine receptors: preclinical progress and the potential impact on treatments for cardiac arrhythmias and heart failure. Expert Opinion on Therapeutic Targets 2020; 24(1) doi: 10.1080/14728222.2020.1708326
|
| 13 |
Pei-Chi Yang, Wayne R. Giles, Luiz Belardinelli, Colleen E. Clancy. Mechanisms of flecainide induced negative inotropy: An in silico study. Journal of Molecular and Cellular Cardiology 2021; 158 doi: 10.1016/j.yjmcc.2021.05.007
|
| 14 |
A. V. Tarasov, E. V. Kazantseva. Pharmacotherapy for atrial fibrillation. The rhythm control strategy (review). Russian Journal of Cardiology 2026; 30(4S) doi: 10.15829/1560-4071-2025-6709
|
| 15 |
Abhishek Kumar, Manisha Gupta, Amratansh Varshney, Rounak Kumar, Patrick Badertscher, Boldizsar Kovacs, Peter Hämmerle, Andrea Papa, Nicolo Sisti. Flecainide fallout: a rare case report of refractory ventricular tachycardia and updated management strategies. European Heart Journal - Case Reports 2025; 9(8) doi: 10.1093/ehjcr/ytaf368
|
| 16 |
|
| 17 |
Hasan Ashraf, Nway Ko Ko, Vatsal Ladia, Pradyumna Agasthi, Tadhg Prendiville, Fergus O’Herlihy, Sai Harika Pujari, Siva K. Mulpuru, Luis Scott, Dan Sorajja. Use of Flecainide in Stable Coronary Artery Disease: An Analysis of Its Safety in Both Nonobstructive and Obstructive Coronary Artery Disease. American Journal of Cardiovascular Drugs 2021; 21(5) doi: 10.1007/s40256-021-00483-9
|
| 18 |
Alessandro Zorzi, Alberto Cipriani, Domenico Corrado. Anti-arrhythmic therapy in athletes. Pharmacological Research 2019; 144 doi: 10.1016/j.phrs.2019.04.027
|
| 19 |
Rachel Lampert, Eugene H. Chung, Michael J. Ackerman, Alonso Rafael Arroyo, Douglas Darden, Rajat Deo, Joe Dolan, Susan P. Etheridge, Belinda R. Gray, Kimberly G. Harmon, Cynthia A. James, Jonathan H. Kim, Andrew D. Krahn, Andre La Gerche, Mark S. Link, Ciorsti MacIntyre, Lluis Mont, Jack C. Salerno, Maully J. Shah. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play. Heart Rhythm 2024; 21(10) doi: 10.1016/j.hrthm.2024.05.018
|
| 20 |
Fadhel A. Alomar, Chengju Tian, Sean R. Bidasee, Zachary L. Venn, Evan Schroder, Nicholas Y. Palermo, Mohammad AlShabeeb, Benson J. Edagwa, Jason J. Payne, Keshore R. Bidasee. HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2). International Journal of Molecular Sciences 2022; 24(1) doi: 10.3390/ijms24010274
|
| 21 |
Sevilay Goktas Sahoglu, Yusuf Enes Kazci, Erkan Tuncay, Tugce Torun, Celal Akdeniz, Volkan Tuzcu, Esra Cagavi. Functional evaluation of the tachycardia patient‐derived iPSC cardiomyocytes carrying a novel pathogenic SCN5A variant. Journal of Cellular Physiology 2022; 237(10) doi: 10.1002/jcp.30843
|
| 22 |
Enrico Paolini, Giulia Stronati, Federico Guerra, Alessandro Capucci. Flecainide: Electrophysiological properties, clinical indications, and practical aspects. Pharmacological Research 2019; 148 doi: 10.1016/j.phrs.2019.104443
|
| 23 |
Hector Martinez-Navarro, Xin Zhou, Alfonso Bueno-Orovio, Blanca Rodriguez. Electrophysiological and anatomical factors determine arrhythmic risk in acute myocardial ischaemia and its modulation by sodium current availability. Interface Focus 2021; 11(1) doi: 10.1098/rsfs.2019.0124
|
| 24 |
Noah R Schneegurt, Christian Wright, Neil Glenn, Inderpal Thethi. Flecainide-Induced Acute Respiratory Distress Syndrome: A Case Report. Cureus 2024; doi: 10.7759/cureus.61637
|
| 25 |
Wayne A. Ray, Cecilia P. Chung, C. Michael Stein, Walter Smalley, Eli Zimmerman, William D. Dupont, Adriana M. Hung, James R. Daugherty, Alyson L. Dickson, Katherine T. Murray. Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation. Annals of Internal Medicine 2023; 176(6) doi: 10.7326/M22-3238
|
| 26 |
Robert C. Klipp, Na Li, Qiongling Wang, Tarah A. Word, Martha Sibrian-Vazquez, Robert M. Strongin, Xander H.T. Wehrens, Jonathan J. Abramson. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2. Heart Rhythm 2018; 15(4) doi: 10.1016/j.hrthm.2017.12.017
|
| 27 |
Hermann A.M. Mucke. Drug Repurposing Patent Applications: January–March 2015. Drug Repurposing, Rescue, and Repositioning 2015; doi: 10.1089/drrr.2015.1506
|
| 28 |
Angelo Montana, Fabrizio Lo Faro, Chiara Turchi, Federica Alessandrini, Arianna Giorgetti. Suicide by flecainide: a case report and review of the literature. Forensic Science, Medicine and Pathology 2026; doi: 10.1007/s12024-026-01188-8
|
| 29 |
Justin Seltzer, Aaron Schneir. Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error. Journal of Medical Toxicology 2024; 20(3) doi: 10.1007/s13181-024-01018-9
|
| 30 |
Samuel Lévy. Cardioversion of recent‐onset atrial fibrillation using intravenous antiarrhythmics: A European perspective. Journal of Cardiovascular Electrophysiology 2021; 32(12) doi: 10.1111/jce.15264
|
| 31 |
Sukhjinder Chauhan, Desiree Morris, Mina Bhatnagar, Pinak Shah, Dhiraj D Narula. A Rare Case Report of Flecainide-Induced Left Bundle Branch Block (LBBB) and Transient Cardiomyopathy. Cureus 2023; doi: 10.7759/cureus.37184
|
| 32 |
Hadrian Hoang-Vu Tran, Audrey Thu, Anu Radha Twayana, Axel Fuertes, Marco Gonzalez, Marina Basta, Maggie James, Krutagni Adwait Mehta, William H. Frishman, Wilbert S. Aronow. Orally Inhaled Flecainide for Paroxysmal Atrial Fibrillation: Emerging Evidence and Therapeutic Potential in Cardioversion to Sinus Rhythm. Cardiology in Review 2025; doi: 10.1097/CRD.0000000000001000
|
| 33 |
Carlos E Guzmán, Carla Gabriela Guzmán-Moreno, José Luis Assad-Morell, Edgar Francisco Carrizales-Sepúlveda, Jalaj Garg, Christopher Wong, Markus Bettin, Stefan Simovic, Mariame Chakir. Flecainide toxicity associated with the use of goji berries: a case report. European Heart Journal - Case Reports 2021; 5(6) doi: 10.1093/ehjcr/ytab204
|
| 34 |
Tyson S. Burnham, Heidi T. May, Tami L. Bair, Jeffrey A. Anderson, Brian G. Crandall, Michael J. Cutler, John D. Day, Roger A. Freedman, Kirk U. Knowlton, Joseph B. Muhlestein, Leenhapong Navaravong, Ravi A. Ranjan, Benjamin A. Steinberg, T. Jared Bunch. Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease. American Heart Journal 2022; 243 doi: 10.1016/j.ahj.2021.08.013
|
| 35 |
Hyung Ki Jeong, Sung Soo Kim, Hyun Kuk Kim, Young Jae Ki, Keun Ho Park, Dong Hyun Choi. A case of sinus arrest in atrial fibrillation with pulmonary embolism after flecainide ingestion. Translational and Clinical Pharmacology 2022; 30(4) doi: 10.12793/tcp.2022.30.e19
|
| 36 |
Hannah Wilson, Declan Patton, Zena Moore, Tom O’Connor, Linda Nugent. Comparison of dronedarone vs. flecainide in the maintenance of sinus rhythm, following electrocardioversion in adults with persistent atrial fibrillation: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy 2021; 7(5) doi: 10.1093/ehjcvp/pvaa018
|
| 37 |
Mehmet Kucukosmanoglu, Mustafa Lutfullah Ardıc, Fadime Koca, Hilmi Erdem Sumbul, Mevlut Koc. The Frontal QRS-T Angle Remains Unchanged in Patients Without Structural Heart Disease Receiving Flecainide Therapy. Journal of Cardiovascular Development and Disease 2026; 13(4) doi: 10.3390/jcdd13040167
|
| 38 |
Juliia Belikova. THE RELATIONSHIP OF THE RATIO TAURINE/ALANINE IN SERUM AND INDICATORS OF HEART RATE VARIABILITY IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DIABETES MELLITUS TYPE 2. The Ukrainian Scientific Medical Youth Journal 2019; 109(1) doi: 10.32345/USMYJ.1(109).2019.6-10
|
| 39 |
Brett J. Wakefield, Anand R. Mehta. Transapical Ablation of Symptomatic Premature Ventricular Contractions in a Patient With Mechanical Mitral and Aortic Valves. Journal of Cardiothoracic and Vascular Anesthesia 2018; 32(6) doi: 10.1053/j.jvca.2017.12.043
|
| 40 |
Shenel A Khan, Soniya Emmanuel, Vivig Shantha Kumar, Resheek Nerella, Basim Shaman Ameen, Dev Patel, Jabez David John, Ranita Bodepudi, Saniya Seher, Sai Sri Penumetcha . Long QT Syndrome With Drugs Used in the Management of Arrhythmias: A Systematic Review. Cureus 2024; doi: 10.7759/cureus.65857
|
| 41 |
Serghei Covantsev, Andia Taghdiri, Anna Bumbu, Natalia Pichugina, Anna Sukhotko. Management of Arrhythmic Mitral Valve Prolapse: Potential Impact and Current Evidence. Reviews in Cardiovascular Medicine 2025; 26(9) doi: 10.31083/RCM38956
|
| 42 |
H. J. te Kolste, G. J. Kimman, T. Germans, S. A. J. Timmer. Between Scylla and Charybdis. Netherlands Heart Journal 2019; 27(7-8) doi: 10.1007/s12471-019-1290-x
|
| 43 |
Deniz Eriş, Feyza Ayşenur Paç. Asymptomatic cardiac tumour with premature ventricular contraction in an athlete: case report. Cardiology in the Young 2022; 32(4) doi: 10.1017/S1047951121003334
|
| 44 |
Satoru FUJII. Newly developed atrial fibrillation in the perioperative setting: what to do next?. Minerva Anestesiologica 2022; 88(6) doi: 10.23736/S0375-9393.22.16470-9
|
| 45 |
Krisztina Lévay, János Madarász, László Hegedűs. Tuning the chemoselectivity of the Pd-catalysed hydrogenation of pyridinecarbonitriles: an efficient and simple method for preparing pyridyl- or piperidylmethylamines. Catalysis Science & Technology 2022; 12(8) doi: 10.1039/D1CY02295D
|
| 46 |
EM Sutrisna. Personalized Medicine of flecainide (The Impact of the CYP2D6 and CYP1A2 Polymorphism on Responses to Flecainide). Biomedical and Pharmacology Journal 2024; 17(1) doi: 10.13005/bpj/2830
|
| 47 |
Elena Valer'evna Yurova, Evgeniya Vladimirovna Rastorgueva, Evgeniy Alekseevich Beloborodov, Dmitriy Evgen'evich Sugak, Evgeniya Sergeevna Pogodina, Yuriy Vladimirovich Saenko. PEPTIDE TOXIN TARGETING SODIUM CHANNELS IN THE MODEL OF ISCHEMIA-REPERFUSION CELL DEATH. Ulyanovsk Medico-biological Journal 2025; (1) doi: 10.34014/2227-1848-2025-1-93-103
|
| 48 |
Soroosh Kiani, Michael N. Sayegh, Rand Ibrahim, Neal K. Bhatia, Faisal M. Merchant, Anand D. Shah, Stacy B. Westerman, David B. De Lurgio, Anshul M. Patel, Christine M. Thompkins, Angel R. Leon, Michael S. Lloyd, Mikhael F. El-Chami. The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease. JACC: Clinical Electrophysiology 2023; 9(7) doi: 10.1016/j.jacep.2022.12.021
|
| 49 |
Lohit Garg, Manasvi Gupta, Syed Rafay Ali Sabzwari, Sahil Agrawal, Manyoo Agarwal, Talha Nazir, Jeffrey Gordon, Babak Bozorgnia, Matthew W. Martinez. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management. Heart Failure Reviews 2019; 24(2) doi: 10.1007/s10741-018-9752-6
|
| 50 |
Athanasios Kartalis, Dimitrios Afendoulis, Petros Voutas, Maria Moutafi, Nikolaos Papagiannis, Stefanos Garoufalis, Nikolaos Kartalis, Nikolaos Smyrnioudis, Antonios Ziakas, Matthaios Didagelos. Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers. International Journal of Translational Medicine 2024; 4(2) doi: 10.3390/ijtm4020021
|
| 51 |
Anton Stolear, Maxim Dulgher, Ju Young Bae, Lila Kaminsky, Gini P Jeyashanmugaraja, Uzodinma Emerenini. Wide Spectrum of Flecainide Toxicity: A Case Report and Literature Review. Cureus 2024; doi: 10.7759/cureus.62923
|
| 52 |
Manish Dwivedi, Sutanu Mukhopadhyay, Shalini Yadav, Kshatresh Dutta Dubey. A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing. Computers in Biology and Medicine 2022; 146 doi: 10.1016/j.compbiomed.2022.105607
|
| 53 |
Pei-Chi Yang, Luiz Belardinelli, Colleen E. Clancy. Mechanisms of Chemical Atrial Defibrillation by Flecainide and Ibutilide. JACC: Clinical Electrophysiology 2024; 10(12) doi: 10.1016/j.jacep.2024.08.009
|
| 54 |
Jiunn Song, Tristan Alfie, E. Kevin Heist, Raymond T. Chung. Terlipressin-Associated Complete Heart Block. ACG Case Reports Journal 2025; 12(4) doi: 10.14309/crj.0000000000001654
|
| 55 |
C. Fielder Camm, A. John Camm. Pathy's Principles and Practice of Geriatric Medicine. 2022; doi: 10.1002/9781119484288.ch29
|
| 56 |
Julian Abdala-Lizarraga, Javier Quesada-Ocete, Blanca Quesada-Ocete, Javier Jiménez-Bello, Aurelio Quesada. Cavotricuspid Isthmus-Dependent Atrial Flutter. Beyond Simple Linear Ablation. Reviews in Cardiovascular Medicine 2024; 25(1) doi: 10.31083/j.rcm2501011
|
| 57 |
Vasudeva Reddy Netala, Sireesh Kumar Teertam, Huizhen Li, Zhijun Zhang. A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies. Cells 2024; 13(17) doi: 10.3390/cells13171471
|
| 58 |
K. D. Tiver, D. K. Martin, J. Quah, A. Lahiri, A. N. Ganesan. Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report. Journal of Medical Case Reports 2023; 17(1) doi: 10.1186/s13256-023-03947-5
|
| 59 |
N.V. Bezditko. Lixarit — clinical and pharmaceutical aspects of efficacy and safety of flecainide acetate generic drug. HYPERTENSION 2022; 14(4) doi: 10.22141/2224-1485.14.4.2021.240254
|
| 60 |
Harold Rivner, Litsa K. Lambrakos. Flecainide Toxicity Leading to Loss of Pacemaker Capture and Cardiac Arrest. JACC: Case Reports 2021; 3(4) doi: 10.1016/j.jaccas.2020.11.030
|
| 61 |
Leah Acker, Kristen Bova Campbell, Colleen Naglee, Brad Taicher, Yuriy S. Bronshteyn. Perioperative Management of Flecainide: A Problem-Based Learning Discussion. A&A Practice 2021; 15(4) doi: 10.1213/XAA.0000000000001443
|
| 62 |
Patryk Klochowicz, Jacek W. Morzycki, Claudia M. Ramírez‐Lozano, Rosa Santillan, Dorota Czajkowska‐Szczykowska. Facile Synthesis of Hydroquinone Linked 3,3’‐Steroid Dimers via a Modified Mitsunobu Protocol. European Journal of Organic Chemistry 2024; 27(25) doi: 10.1002/ejoc.202400309
|
| 63 |
Francesco Moccia, Valentina Brunetti, Teresa Soda, Pawan Faris, Giorgia Scarpellino, Roberto Berra-Romani. Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy. Journal of Clinical Medicine 2023; 12(16) doi: 10.3390/jcm12165295
|
| 64 |
Muhammad Haris Ilyas, Amaan Mohammad Sharih, Jamila Tukur Jido, Abdul Rahman Zulfiqar Ali, Ava Khoshnaghsh, Mehak Nadeem, Syeda Anum Zahra. Screening for Atrial Fibrillation: Risks, Benefits, and Implications On Future Clinical Practice. Current Treatment Options in Cardiovascular Medicine 2024; 26(8) doi: 10.1007/s11936-024-01047-1
|
| 65 |
Abdulrahman K Alraee, Tarique S Chachar, Ammar S Shaaban, Husam A Noor. Early Recognition and Management of Flecainide Toxicity: A Case Report and Literature Review. Cureus 2024; doi: 10.7759/cureus.73683
|
| 66 |
Jonathan W. Waks, Peter Zimetbaum. Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation. Journal of Cardiovascular Pharmacology and Therapeutics 2017; 22(1) doi: 10.1177/1074248416651722
|
| 67 |
Trevor Wolchover, Leili Pourafkari, Vishva Dev, Jasprit Takher. Flecainide Toxicity Leading to Transient Heart Failure With Reduced Ejection Fraction: A Case Study. Cureus 2025; doi: 10.7759/cureus.84100
|
| 68 |
Anders Einum, Philip von Brandis, Elisabeth Leirgul, Cathrine Ebbing. Monochorionic Twin Pregnancy Complicated by Arrhythmia in One Twin: Longitudinal Hemodynamic Effects of Flecainide Cardioversion Assessed by Fetal Venous Doppler. Journal of Fetal Medicine 2023; 10(03) doi: 10.1055/s-0043-1774753
|
| 69 |
Fernando Wangüemert Pérez, Julio Salvador Hernández Afonso, María del Val Groba Marco, Eduardo Caballero Dorta, Luis Álvarez Acosta, Oscar Campuzano Larrea, Guillermo Pérez, Josep Brugada Terradellas, Ramón Brugada Terradellas. Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia. Revista Española de Cardiología (English Edition) 2018; 71(3) doi: 10.1016/j.rec.2017.04.032
|
| 70 |
Isabelle Malhamé, Christy Gandhi, Gofran Tarabulsi, Matthew Esposito, Kristin Lombardi, Antony Chu, Kenneth K Chen. Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia. Obstetric Medicine 2019; 12(2) doi: 10.1177/1753495X18808118
|
| 71 |
Gheorghe-Andrei Dan, Dobromir Dobrev. Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging. IJC Heart & Vasculature 2018; 21 doi: 10.1016/j.ijcha.2018.08.005
|
| 72 |
Pratik Khatiwada, Lindsey Clark, Arjun Khunger, Bhimesh B Rijal, Jody Ritter. A Case Report of Flecainide Toxicity With Review of Literature. Cureus 2022; doi: 10.7759/cureus.22261
|
| 73 |
Shumin Fan, Keith Norman Norton. Flecainide Intoxication. American Journal of Forensic Medicine & Pathology 2025; 46(3) doi: 10.1097/PAF.0000000000001026
|
| 74 |
James Boris, Hussein Al-Sudani, Aaron Brophy. Flecainide overdose-induced wide-complex tachyarrhythmia treated with sodium bicarbonate infusion. BMJ Case Reports 2024; 17(6) doi: 10.1136/bcr-2023-256391
|
| 75 |
Giampaolo Morciano, Alessandro Rimessi, Simone Patergnani, Veronica A.M. Vitto, Alberto Danese, Asrat Kahsay, Laura Palumbo, Massimo Bonora, Mariusz R. Wieckowski, Carlotta Giorgi, Paolo Pinton. Calcium dysregulation in heart diseases: Targeting calcium channels to achieve a correct calcium homeostasis. Pharmacological Research 2022; 177 doi: 10.1016/j.phrs.2022.106119
|
| 76 |
Chrysovalantou Nikolaidou, Konstantinos Kouskouras, Nikolaos Fragakis, Vassilios P. Vassilikos, Haralambos Karvounis, Theodoros D. Karamitsos. Bolus Intravenous Procainamide in Patients with Frequent Ventricular Ectopics during Cardiac Magnetic Resonance Scanning: A Way to Ensure High Quality Imaging. Diagnostics 2021; 11(2) doi: 10.3390/diagnostics11020178
|
| 77 |
Jordi Cano, Esther Zorio, Andrea Mazzanti, Miguel Ángel Arnau, Beatriz Trenor, Silvia G. Priori, Javier Saiz, Lucia Romero. Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.580481
|
| 78 |
Dario Turturiello, Riccardo Cappato. The many NOs to the use of Class IC antiarrhythmics: weren’t the guidelines too strict?. European Heart Journal Supplements 2022; 24(Supplement_I) doi: 10.1093/eurheartjsupp/suac073
|
| 79 |
Fernando Wangüemert Pérez, Julio Salvador Hernández Afonso, María del Val Groba Marco, Eduardo Caballero Dorta, Luis Álvarez Acosta, Oscar Campuzano Larrea, Guillermo Pérez, Josep Brugada Terradellas, Ramón Brugada Terradellas. La flecainida reduce las arritmias ventriculares en pacientes con taquicardia ventricular polimórfica catecolaminérgica genotipo RyR2 positivo. Revista Española de Cardiología 2018; 71(3) doi: 10.1016/j.recesp.2017.04.014
|
| 80 |
Joachim R. Ehrlich, Christiane Look, Karel Kostev, Carsten W. Israel, Andreas Goette. Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany. International Journal of Cardiology 2019; 278 doi: 10.1016/j.ijcard.2018.11.133
|
| 81 |
Manuel Kraft, Antonius Büscher, Felix Wiedmann, Yannick L’hoste, Walter E. Haefeli, Norbert Frey, Hugo A. Katus, Constanze Schmidt. Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.638445
|
| 82 |
Редакція «Українського медичного часопису». Флекаїнід у лікуванні та утриманні шлуночкових екстрасистол. Ukrainian Medical Journal 2026; doi: 10.32471/umj.1680-3051.275046
|
| 83 |
Maia Eng, William Wung, Uma N Srivatsa, Gagan D Singh. “C” Trouble: Class IC Anti-arrhythmic Toxicity. Journal of Cardiovascular Medicine and Cardiology 2017; 4(2) doi: 10.17352/2455-2976.000047
|
| 84 |
Jennifer A. Ferrante, Muzammel Rizvi, Sami Sakaan, John Eick, B. Tate Cutshall. Consequences of AV blockade omission in flecainide therapy. The Nurse Practitioner 2021; 46(7) doi: 10.1097/01.NPR.0000753872.27819.f7
|
| 85 |
Erind Gjermeni, Andreas Bollmann, Gerhard Hindricks, Andreas Müssigbrodt. Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation. Case Reports in Cardiology 2019; 2019 doi: 10.1155/2019/4820652
|
| 86 |
Yangyang Wang, Yaping Wang, Ya Hu, Jihan Wang. Biology-Informed Matrix Factorization: An AI-Driven Framework for Enhanced Drug Repositioning. Biology 2025; 14(5) doi: 10.3390/biology14050549
|
| 87 |
Joana Certo Pereira, Maria Rita Lima, Francisco Moscoso Costa, Daniel A. Gomes, Sérgio Maltês, Gonçalo Cunha, Hélder Dores, Pedro Adragão. Stroke in Athletes with Atrial Fibrillation: A Narrative Review. Diagnostics 2024; 15(1) doi: 10.3390/diagnostics15010009
|
| 88 |
Bao Hui Poh, Jan Hau Lee, Abdul Alim Abdul Haium, Tze Liang Jonathan Choo. Complete Heart Block Secondary to Flecainide Toxicity: Is It Time for CYP2D6 Genotype Testing?. Pediatrics 2020; 146(1) doi: 10.1542/peds.2019-2608
|